CompoAtlas

GINGEMBRE

Food supplement declared in France, declaration No 2017-8-449, decision dated 24 August 2017

GINGEMBRE (LABORATOIRES FENIOUX) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
LABORATOIRES FENIOUX
Food business operator placing the product on the market
Laboratoires Fenioux
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
6 gélules par jour
Directions for use
3 à 6 gélues par jour réparties en 2 prises avec un grand verre d'eau, 10 minutes avant les repas
Not recommended for (according to the manufacturer)
Femmes enceintes

Declaration 204824, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Zingiber officinale RoscoeRhizomePoudre (de plantes séchées ou broyées)1.68 g

Other ingredients

gélatine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2017. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé chez les femmes enceintes

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : LABORATOIRES FENIOUX

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line